Hypoestrogenism in young women and its influence on bone mass density

Gynecological Endocrinology

Volumn 26, Issue 9, 2010, Pages 652-657

  Meczekalski, Blazej ^a   Podfigurna Stopa, Agnieszka ^a   Genazzani, Andrea Riccardo ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

amenorrhea; anorexia nervosa; estrogens; gonadal dysgenesis; Osteoporosis

Indexed keywords

ANDROGEN; CALCIUM; COLONY STIMULATING FACTOR 1; ESTRADIOL; ESTROGEN; FOLLITROPIN; GESTAGEN; GROWTH HORMONE; INTERLEUKIN 1; INTERLEUKIN 6; LUTEINIZING HORMONE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PRASTERONE; PROLACTIN; RECOMBINANT LEPTIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY; BONE MASS; BONE REMODELING; BONE TURNOVER; CALCIUM DEFICIENCY; CALCIUM INTAKE; CLIMACTERIUM; CYTOKINE PRODUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; ESTRADIOL BLOOD LEVEL; FERTILE PERIOD; FOLLITROPIN BLOOD LEVEL; FRACTURE; GENE EXPRESSION; GONADAL DYSGENESIS; HORMONAL THERAPY; HUMAN; HYPERPROLACTINEMIA; HYPOESTROGENISM; HYPOPITUITARISM; INHIBITION KINETICS; KALLMANN SYNDROME; LUTEINIZING HORMONE BLOOD LEVEL; OSSIFICATION; OSTEOPENIA; OSTEOPOROSIS; OVARY INSUFFICIENCY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

BONE DENSITY; ENDOCRINE SYSTEM DISEASES; ESTROGENS; FEMALE; GONADAL DYSGENESIS; HUMANS; HYPOGONADISM; OSTEOGENESIS; OSTEOPOROSIS; YOUNG ADULT;

EID: 77955804234     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.486452     Document Type: Review

References (59)

1. Sowers MF. Lower peak bone mass and its decline. Baillieres Best Pract Res Clin Endocrinol Metab 2000;14:317-329.
2. Sowers MF, Scholl T, Harris L, Jannausch M. Bone loss in adolescent and adult pregnant women. Obstet Gynecol 2000;96:189-193.
3. Ho AY, Kung AW. Determinants of peak bone mineral density and bone area in young women. J Bone Miner Metab 2005;23:470-475.
4. Seeman E. Pathogenesis of bone fragility in women and men. Lancet 2002;359:1841-1850.
5. Cárdenas Morales BE, Pérez Campos E. The role of hypoestrogenism in postmenopausal osteoporosis-new perspectives [Bibliographic review]. Ginecol Obstet Mex 2003;71:187-194.
6. Giner M, Rios MA, Montoya MA, Vázquez MA, Naji L, Pérez-Cano R. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J Steroid Biochem Mol Biol 2009;113:46-51.
7. Mircea CN, Lujan ME, Pierson RA. Metabolic fuel and clinical implications for female reproduction. J Obstet Gynaecol Can 2007;29:887-902.
8. Bakalov VK, Bondy CA. Fracture risk and bone mineral density in Turner syndrome. Rev Endocr Metab Disord 2008;9:145-151.
9. Gordon CM Bone density issues in the adolescent gynecology patient. J Pediatr Adolesc Gynecol 2000;13:157-161.
10. Lorenc RS, Karczmarewicz E, Gluszko P, Ksiezopolska-Orlowska K, Misiorowski W, Franek E, Horst-Sikorska W, Kaleta M, Meczekalski B, Warenik-Szymankiewicz A, et al. Zalecenia postȩpowania diagnostycznego i leczniczego w osteoporozie. Obnizenie czestosci zlaman poprzez efektywna profilaktyke i leczenie, Terapia; 2007.
11. Stubbs B. Antipsychotic-induced hyperprolactinaemia in patients with schizophrenia: considerations in relation to bone mineral density. J Psychiatr Ment Health Nurs 2009; 16:838-842.
12. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings SR. J Clin Endocrinol Metab 1998;83:2239-2243.
13. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 1991; 265:1133-1138.
14. Davies JH, Evans BAJ, Gregory JW. Bone acquisition in healthy children. Arch Dis Child 2005;87:2391-2394.
15. DiVasta AD, Gordon CM. Bone health in adolescents. Adolesc Med Clin 2006;17:639-652.
16. Mølgaard C, Larnkjær A, Cashman KD, Lamberg-Allardt C, Jakobsen J, Michaelsen KF. Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? Bone 2010;46:432-439.
17. Johnston CC, Slemenda CW. Determinants of peak bone mass. Osteoporosis Int 1993;(Suppl 1):S54-S55.
18. Gibson JH, Mitchell A, Harries MG, Reeve J. Nutritional and exercise-related determinants of bone density in elite female runners. Osteoporos Int 2004;15:611-618.
19. Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab 2002;87:3162-3168.
20. Imai Y, Youn MY, Kondoh S, Nakamura T, Kouzmenko A, Matsumoto T, Takada I, Takaoka K, Kato S. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. Ann NY Acad Sci 2009;1173(Suppl 1):E31-E39.
21. Weitzmann MN, Pacifici R. Estrogen regulation of immune cell bone interactions. Ann N Y Acad Sci 2006;1068:256-274.
22. Taes Y, Lapauw B, Vandewalle S, Zmierczak H, Goemaere S, Vanderschueren D, Kaufman JM, TSjoen G. Estrogenspecific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity. Bone 2009;45:392-397.
23. Norian JM, Zeitlian G, Adel G, Freeman RG, Santoro NF, Pal L. Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance? Fertil Steril 2009;91:542-548.
24. Adachi M, Takayanagi R. Role of androgens and DHEA in bone metabolism. Clin Calcium 2006;16:61-66.
25. Golden NH, Carlson JL. The pathophysiology of amenorrhea in the adolescent. Ann NY Acad Sci 2008;1135:163-178.
26. Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, Genazzani AR. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 2008;24:4-11.
27. Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, Wexler T, Herzog DB, Klibanski A. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 2009;94:4710-4716.
28. Warren MP, Chua AT. Exercise-induced amenorrhea and bone health in the adolescent athlete. Ann NY Acad Sci 2008;1135:244-252.
29. Fenichel RM, Warren MP. Anorexia, bulimia, and the athletic triad: evaluation and management. Curr Osteoporos Rep 2007;5:160-164.
30. Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997; 29:i-ix.
31. Burrows M, Shepherd H, Bird S, MacLeod K, Ward B. The components of the female athlete triad do not identify all physically active females at risk. J Sports Sci 2007;25:1289-1297.
32. Nattiv A, Loucks AB, Manore MM, Sanborn CF, Sundgot-Borgen J, Warren MP; American College of Sports Medicine. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007;39:1867-1882.
33. Fechner A, Fong S, McGovern P. A review of Kallmann syndrome: genetics, pathophysiology, and clinical management. Obstet Gynecol Surv 2008;63:189-194.
34. Taylor HS, Cass I, Lang R. Bone loss in Kallmann syndrome. Obstet Gynecol 1996;88:734.
35. Von Ranson, Iacono WG, McGue M. Disordered eating and substance use in an epidemiological sample. I. Associations within individuals. Int J Eat Disors 2002;31:389-403.
36. American Psychiatric Association Diagnostic and Statistical Manual for Mental Disorders. 4th edn. Washington DC: APA Press; 1994.
37. Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 2009;56:729-737.
38. Ohwada R, Hotta M, Sato K, Shibasaki T, Takano K. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. Endocr J 2007; 54:953-959.
39. Misra M, Aggarwal A, Miller KK, Almazan C, Worley M, Soyka LA, Herzog DB, Klibanski A. Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 2004;114:1574-1583.
40. Bolton JG, Patel S, Lacey JH, White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005;16:1955-1962.
41. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, Herzog D, Klibanski A. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000;133:790-794.
42. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3864-3870.
43. Lucas AR, Beard CM, OFallon WM, Kurland LT. 50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry 1991;148: 917-922.
44. Jayasinghe Y, Grover SR, Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG 2008;115:304-315.
45. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002;87:4935-4941.
46. OKeane V. Antipsychotic-induced hyperproalctinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia. J Psychopharmacol 2008;22:70-75.
47. Zadrozna-Sliwka B, Bolanowski M, Kaluzny M, Syrycka J. Bone mineral density and bone turnover in hyperprolactinaemia of various origin. Endokrynol Pol 2007;58: 116-122.
48. Duntas LH. Prolactinomas in children and adolescents-consequences in adult life. J Pediatr Endocrinol Metab 2001; 14:1227-1232.
49. Conway GS. Considerations for transition from paediatric to adult endocrinology: women with Turners syndrome. Growth Horm IGF Res 2004;14:S77-S84.
50. Han TS, Cadge B, Conway GS. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turners syndrome. Clin Endocrinol (Oxf) 2006;65:643-647.
51. Ross JL, Long LM, Feuillan P, Cassorla F, Cutler GB Jr. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turners syndrome. J Clin Endocrinol Metab 1991;73:355-359.
52. Rebar RW. Premature ovarian failure. Obstet Gynecol 2009;113:1355-1363.
53. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis 2006;6:1-9.
54. Uygur D, Sengül O, Bayar D, Erdinç S, Batio ǧlu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet 2005;273: 17-19.
55. Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83:1327-1332.
56. Brydøy M, Fossä SD, Dahl O, Bjøro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 2007;46:480-489.
57. McCune JS, Games DM, Espirito JL. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors. J Oncol Pharm Pract 2005;11:37-43.
58. Oparil S. Hormone therapy of premature ovarian failure: the case for natural estrogen. Hypertension 2009;53:745-746.
59. Vescovi JD, Jamal SA, De Souza MJ. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int 2008;19:465-478.